20092023

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Curriculum

Positions held
since January 2009 Full professor (chair) of pharmacy (professor i lægemiddelvidenskab) at Dept. Chemistry and Physics, University of Southern Denmark, Odense, Denmark
01/2009 to 12/2010 adjunct professor (professor II) at Dept. Pharmaceutics & Biopharma-ceutics, Institute of Pharmacy, University of Tromsø (UiT), Tromsø, Norway
04/1998 to 12/2008 Full professor (chair) in pharmaceutics (professor i legemiddelteknologi) at Dept. of Pharmaceutics & Biopharmaceutics, Inst. Pharmacy, Tromsø, Norway
02/1992 to 03/1998 assistant professor (adjunkt) in pharmaceutics, Institute of Pharmacy, Department of Pharmaceutical Technology, Albert-Ludwigs-University (ALU) Freiburg, Germany
02/1991 to 02/1992 Postdoctoral fellow, personal grant Deutsche Forschungsgemeinschaft Bonn, Germany
08/1987 to 02/1991 Head of department of pharmaceutical affairs and registration (part time), GRY Pharma GmbH, Kirchzarten, Germany, (medium-sized pharmaceutical company)
01/1986 to 08/1987 Scientific officer at department of pharmaceutical affairs and registration (part time), GRY Pharma GmbH, Kirchzarten, Germany

Degrees earned
May 1998 Dr. rer. nat. habil. and venia legendi in pharmaceutics (Pharmazeutische Technologie) Faculty of Chemistry and Pharmacy, ALU Freiburg, Germany
July 1990 Dr. rer. nat. in pharmaceutics „summa cum laude“, Faculty of Chemistry and Pharmacy, ALU Freiburg, Germany, supervisor Prof. Dr. K.H. Bauer
Dec. 1985 „Approbation als Apotheker“ (equivalent to master of pharmacy / cand. pharm.), Bayerisches Staatsministerium des Inneren, Munich, Germany

Foreign research periods
2008 Guest professor at Inst. Pharmacy, ALU Freiburg, Germany, Prof. Dr. R. Schubert
2006 Guest professor at Tumor Biology Center, Freiburg, Germany, Prof. Dr. C. Unger 
2003 Guest professor at Tumor Biology Center, Freiburg, Germany, Prof. Dr. C. Unger
1995 Guest researcher at Dept. Pharmaceutics, Univ. Kuopio, Finland, Prof. Dr. P. Paronen,
1993 Guest researcher at Centre for Drug Delivery Research, School of Pharmacy, Univ. London, U.K., Prof. Dr. G. Gregoriadis
02/1991 to 02/1992 Postdoctoral researcher at Centre for Drug Delivery Research (CDDR), School of Pharmacy, University of London, U.K., Prof. Dr. G. Gregoriadis

Administrative and managenment experience
At SDU
since 08/2010 leader for pharmacy study program and head of program committee

At University of Tromsø
1998 – 2000 & 2005 - 2006 Head of Dept. Pharmaceutics & Biopharmaceutics, Inst. Pharmacy (IFA)
2001 - 2004 Leader of research center “Drug Transport & Drug Delivery”
1998 - 2000 & 2002 –2005 Member of institute board (instituttstyret), IFA
2004 - 2006 Member of teaching committee (undervisningsutvalget) at Medical Faculty
2000 - 2001 Member of Research Committee (forskningsutvalget) at Medical Faculty

Supervision
main supervisor of 8 PhDs (defended) and 4 ongoing phD-students, co-supervisor of 4 ongoing PhD-students
main supervisor of 2 former and 2 ongoing postdoctoral fellows

 

 

Research areas

  • Pharmaceuticals
  • Drug delivery from nanoparticles
  • Nanotechnology
  • Processing of animal and vegetable raw materials for food, feed and pharmaceuticals
  • Development of new drugs
  • Chromatography
  • Lipidomics
  • Cancer
  • Caractirisation and manipulation of nano structures
  • Drug delivery from nanoparticles
  • Nanomaterials
  • Nanotechnology
  • Cancer
  • Pharmaceuticals
  • Development of new drugs
  • Particles, cores
  • Nanotechnology and nanoscience
  • Nanomedicine

Fingerprint Dive into the research topics where Martin Brandl is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Solubility and supersaturation: https://doi.org/10.1515/9783110559835-002

Bauer-Brandl, A. & Brandl, M., 20. Jan 2020, Solubility in Pharmaceutical Chemistry. Saal, C. & Nair, A. (eds.). 1st ed. Berlin: De Gruyter, p. 27-70

Research output: Chapter in Book/Report/Conference proceedingBook chapterEducation

A dynamic in vitro permeation study on solid mono- and diacyl-phospholipid dispersions of celecoxib

Jacobsen, A-C., Elvang, P. A., Bauer-Brandl, A. & Brandl, M., 15. Jan 2019, In : European Journal of Pharmaceutical Sciences. 127, p. 199-207

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
  • 80 Downloads (Pure)

    Co-existing colloidal phases of human duodenal aspirates: Intraindividual fluctuations and interindividual variability in relation to molecular composition

    Elvang, P. A., Bohsen, M. S., Stein, P. C., Bauer-Brandl, A., Riethorst, D., Brouwers, J., Augustijns, P. & Brandl, M., 5. Jun 2019, In : Journal of Pharmaceutical and Biomedical Analysis. 170, June, p. 22-29

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Exploring environmental sources of archaeal lipids for improving liposomes for oral drug delivery

    Bohsen, M. S., Zipfel, K. H., Uri, N., Nielsen, P. H., Brandl, M. & Treusch, A. H., 11. Nov 2019.

    Research output: Contribution to conference without publisher/journalPosterResearch

    File

    High-Throughput Dissolution/Permeation Screening -A 96-Well Two-Compartment Microplate Approach

    Jacobsen, A-C., Krupa, A., Brandl, M. & Bauer-Brandl, A., 10. May 2019, In : Pharmaceutics. 11, 5, p. 227

    Research output: Contribution to journalJournal articleResearchpeer-review

    Open Access
    File
  • 46 Downloads (Pure)

    Activities

    • 16 Talks and presentations in private or public companies
    • 7 Conference presentations

    Dynamic dissolution-/permeation- testing

    Martin Brandl (Guest lecturer)
    17. Jun 2019

    Activity: Talks and presentationsConference presentations

    Towards a better understanding of amorphous solid dispersions

    Martin Brandl (Guest lecturer)
    29. Jan 2019

    Activity: Talks and presentationsTalks and presentations in private or public companies

    Towards novel bioavailability tools

    Martin Brandl (Guest lecturer)
    28. Jan 2019

    Activity: Talks and presentationsTalks and presentations in private or public companies

    Promoting the mechanistic understanding of enabling oral formulations: what can in-vitro tools contribute?

    Martin Brandl (Guest lecturer)
    6. Dec 2018

    Activity: Talks and presentationsTalks and presentations in private or public companies

    In vitro permeation / absorption: the basics

    Martin Brandl (Guest lecturer)
    24. Oct 2018

    Activity: Talks and presentationsTalks and presentations in private or public companies

    Projects

    Prizes

    Instrument donation

    Martin Brandl (Recipient) & Annette Bauer-Brandl (Recipient), 1. Aug 2019

    Prize: Prizes, scholarships, distinctions

  • Multi-angle light scattering detector for existing Asymmetrical Flow Field-Flow Fractionation (AF4) instrument

    Martin Brandl (Recipient), Koji Kinoshita (Recipient), Changzhu Wu (Recipient), Judith Kuntsche (Recipient), Paul C. Stein (Recipient), Stefan Vogel (Recipient), Annette Bauer-Brandl (Recipient), Daniel Bar-Shalom (Recipient), Jette Jacobsen (Recipient) & Camilla Foged (Recipient), 21. Nov 2018

    Prize: Prizes, scholarships, distinctions